Azithromycin versus doxycycline for treatment of erythema migrans: Clinical and microbiological findings (original) (raw)
References
Stanek, G., Pletschette, M., Flamm, H., Hirschl, A. M., Aberer, E., Kristoferitsch, W., Schmutzhard, E. European Lyme borreliosis. Ann. N. Y. Acad. Sci. 539 (1988) 274–282. Google Scholar
Ciesielski, C. A., Markowitz, L. E., Horsley, R., Hightower, A. R., Russell, H., Broome, C. V. The geographic distribution of Lyme disease in the United States. Ann. N. Y. Acad. Sci. 539 (1988) 283–288. Google Scholar
Burgdorfer, W., Barbour, A. G., Hayes, S. F., Benach, J. L., Grunwaldt, E., Davis, J. P. Lyme disease: a tick-borne spirochetosis? Science 216 (1982) 1317–1319. Google Scholar
Steere, A. C., Bartenhagen, N. H., Craft, J. E., Hutchinson, G. J., Newman, J. H., Pachner, A. R., Rahn, D. W., Sigal, L. H., Taylor, E., Malawista, S. E. Clinical manifestations of Lyme disease. Zbl. Bakt. Hyg. A 263 (1986) 201–205. Google Scholar
Steere, A. C., Malawista, S. E., Bartenhagen, N. H., Spieler, P. N., Newman, J. H., Rahn, D. W., Hutchinson, G. J., Green, J., Snydman, D. R., Taylor, E. The clinical spectrum and treatment of Lyme disease. Yale J. Biol. Med. 57 (1984) 453–461. Google Scholar
Steere, A. C., Hutchinson, G. J., Rahn, D. W. A., Sigal, L. H., Craft, J. E., DeSanna, E. T., Malawista, S. E. Treatment of the early manifestations of Lyme disease. Ann. Intern. Med. 99 (1983) 22–26. Google Scholar
Weber, K., Neubert, U., Thurmayr, R. Antibiotic therapy in early erythema migrans disease and related disorders. Zbl. Bakt. Hyg. A 263 (1986) 377–388. Google Scholar
Berger, B. W. Treatment of erythema chronicum migrans of Lyme disease. Ann. N. Y. Acad. Sci. 539 (1988) 346–351. Google Scholar
Weber, K., Preac-Mursic, V., Neubert, U., Thurmayr, R., Herzer, P., Wilske, B., Schierz, G., Marget, W. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann. N. Y. Acad. Sci. 539 (1988) 324–345. Google Scholar
Preac-Mursic, A., Weber, K., Pfister, H. W., Wilske, B., Gross, B., Baumann, A., Prokop, J. Survival of_Borrelia burgdorferi_ in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355–359. Google Scholar
Foulds, G., Shepard, R. M., Johnson, R. B. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25 Suppl. A (1990) 73–82. Google Scholar
Preac-Mursic, V., Wilske, B., Schierz, G., Suss, E., Gross, B. Comparative antimicrobial activity of the new macrolides against_Borrelia burgdorferi_. Eur. J. Clin. Microbiol. 8 (1989) 651–653. Google Scholar
Johnson, R. C., Kodner, C., Russell, M.:In vitro and_in vivo_ susceptibility of_Borrelia burgdorferi_ to three antimicrobial agents. 4th European Congress of Clinical Microbiology, Nice 1989, Abstract No. 941, p. 43.
Johnson, R. C., Kodner, C., Russell, M., Girard, D.In-vitro and_in-vivo_ susceptibility of_Borrelia burgdorferi_ to azithromycin. J. Antimicrob. Chemother. 25 Suppl. A (1990) 33–38. Google Scholar
Strle, F., Ružič, E., Cimperman, J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J. Antimicrob. Chemother. 30 (1992) 543–550. Google Scholar
Massarotti, E. M., Luger, S. W., Rahn, D. W., Messner, R. P., Wong, J. B., Johnson, R. C., Steere, A. C. Treatment of early Lyme disease. Am. J. Med. 92 (1992) 396–403. Google Scholar
Preac-Mursic, V., Wilske, B., Schierz, G. European_Borrelia burgdorferi_ isolated from humans and ticks. Culture conditions and antibiotic susceptibility. Zbl. Bakt. Hyg. A 263 (1986) 112–118. Google Scholar
Steere, A. C., Malawista, S. E., Newman, J. H., Spieler, P. N., Bartenhagen, N. H. Antibiotic therapy in Lyme disease. Ann. Intern. Med. 93 (1980) 1–8. Google Scholar
Berger, B. W. Treating erythema chronicum migrans of Lyme disease. J. Am. Acad. Dermatol. 15 (1986) 459–463. Google Scholar
Dattwyler, R. J., Halperin, J. J. Failure of tetracycline therapy in early Lyme disease. Arthritis Rheumat. 30 (1987) 448–450. Google Scholar
Preac-Mursic, V., Wilske, B., Schierz, G., Holmburger, M., Suss, E.In vitro and_in vivo_ susceptibility of_Borrelia burgdorferi_. Eur. J. Clin. Microbiol. 6 (1987) 424–426. Google Scholar
Wretlind, B., Johnson, R. C., Hansen, K., Preac-Mursic, V. Antibiotic susceptibility of_Borrelia burgdorferi_ in_in vitro_ and animal models. Scand. J. Infect. Dis. Suppl. 77 (1991) 143–144. Google Scholar
Johnson, R. C., Kodner, C., Russell, M., Duray, H. P. Experimental infection of the hamster with_Borrelia burgdorferi_. N. Y. Acad. Sci. 539 (1988) 258–263. Google Scholar
Standiford, H. C. Tetracyclines and chloramphenicol. In:Mandell, G. L., Douglas, R. G. Jr., Bennett, J. E. (eds.): Principles and practice of infectious diseases. Churchill Livingstone, New York 1990, pp. 284–295. Google Scholar
Dotevall, L., Alestig, K., Hanner, P., Norkrans, G., Hagberg, L. The use of doxycycline in nervous system_Borrelia burgdorferi_ infection. Scand. J. Infect. Dis. 53 (1988) 74–79. Google Scholar
Dotevall, L., Hagberg, L. Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob. Agents Chemother. 33 (1989) 1078–1080. Google Scholar
Bright, G. M., Nagel, A. A., Bordner, J., Desai, K. A., Dibrino, J. N., Nowakowska, J., Vincent, L., Watrous, R. M., Sciavolino, F. C., English, A. R., Retsema, J. A., Anderson, M. R., Brennan, L. A., Borovoy, R. J., Cimochowski, C. R., Faiella, J. A., Girard, A. E., Girard, D., Herbert, C., Manousos, M., Mason, R. Synthesis,in vitro and_in vivo_ activity of novel 9-deoxo-9a-aza-9a homoerythromycin A derivates: a new class of macrolide antibiotics, the azalides. J. Antibiotics 41 (1988) 1029–1047. Google Scholar
Girard, A. E., Girard, D, Retsema, J. A. Correlation of the extravascular pharmacokinetics of azithromycin with_in vivo_ efficacy in models of localized infection. J. Antimicrob. Chemother. 25 Suppl. A (1990) 61–71. Google Scholar
Shepard, R. M., Falkner, F. C. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother. 25 Suppl. A (1990) 49–60. Google Scholar
Retsema, J. A., Girard, A. E., Girard, D., Milisen, W. P. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy_in vivo_. J. Antimicrob. Chemother. 25 Suppl. A (1990) 83–89. Google Scholar
Weber, K., Preac-Mursic, V., Wilske, B., Thurmayr, R., Neubert, U., Scherwitz, C. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 18 (1990) 91–96. Google Scholar